, TESTBANK FOR Clinical Consult to Psychiatric
Mental Health Management for Nurse
Practitioners, 3rd Edition Rhoads
Notes
1- The file is chapter after chapter.
2- We have shown you few pages sample.
3- The file contains all Appendix and Excel sheet
if it exists.
4- We have all what you need, we make update
at every time. There are many new editions
waiting you.
5- If you think you purchased the wrong file You
can contact us at every time, we can replace it
with true one.
Our email:
,Clinical Consult to Psychiatric Mental Health
Management for Nurse Practitioners
Third Edition
Jacqueline Rhoads, PhD, ACNP-BC, ANP-C, PMHNP-BE, FAANP
Editor
Copyright © Springer Publishing Company
,Copyright © 2025 Springer Publishing Company, LLC
All rights reserved.
No part of this publication may be reproduced, stored in a retrieval system, or transmitted in
any form or by any means, electronic, mechanical, photocopying, recording, or otherwise,
without the prior permission of Springer Publishing Company, LLC, or authorization through
payment of the appropriate fees to the Copyright Clearance Center, Inc., 222 Rosewood
Drive, Danvers, MA 01923, 978-750-8400, fax 978-646-8600, or at
www.copyright.com.
Springer Publishing Company, LLC
902 Carnegie Center/Suite 140, Princeton, NJ 08540
www.springerpub.com
connect.springerpub.com
ISBN: 978-0-8261-5699-0
The author and the publisher of this Work have made every effort to use sources believed to
be reliable to provide information that is accurate and compatible with the standards
generally accepted at the time of publication. Because medical science is continually
advancing, our knowledge base continues to expand. Therefore, as new information
becomes available, changes in procedures become necessary. We recommend that the
reader always consult current research and specific institutional policies before performing
any clinical procedure or delivering any medication. The author and publisher shall not be
liable for any special, consequential, or exemplary damages resulting, in whole or in part,
from the readers’ use of, or reliance on, the information contained in this book. The publisher
has no responsibility for the persistence or accuracy of URLs for external or third-party
Copyright © Springer Publishing Company
,Internet websites referred to in this publication and does not guarantee that any content on
such websites is, or will remain, accurate or appropriate.
Copyright © Springer Publishing Company
, Contents
Chapters 1–7 intentionally omitted from the Test Bank
Chapter 8: Substance-Related and Addictive Disorders 1
Chapter 9: Psychotic Disorders 6
Chapter 10: Bipolar and Related Disorders 10
Chapter 11: Anxiety Disorders 14
Chapter 12: Obsessive-Compulsive and Related Disorders 18
Chapter 13: Depressive Disorders 22
Chapter 14: Somatoform Disorders 27
Chapter 15: Dissociative Disorders 31
Chapter 16: Sexual Dysfunction 35
Chapter 17: Feeding and Eating Disorders 40
Chapter 18: Personality Disorders 45
Chapter 19: Sleep–Wake Disorders 50
Chapter 20: Trauma and Stressor-Related Disorders 55
Chapter 21: Disruptive, Impulse Control, and Conduct
Disorders 60
Copyright © Springer Publishing Company
,Chapter 22: Disorders Usually Presenting in Childhood 64
Chapter 23: Neurocognitive Disorders 68
Copyright © Springer Publishing Company
, Chapter 8
Substance-Related and Addictive Disorders
1. Which institution describes the effective treatment principles of substance use disorders?
A. Anti-Drug Abuse Committee
B. Narcotics Control Bureau (NCB)
C. National Centre for Drug Abuse (NCD)
*D. The National Institute on Drug Abuse (NIDA)
Answer: D) The National Institute on Drug Abuse (NIDA)
Rationale: The National Institute on Drug Abuse (NIDA) outlines effective treatment principles as
NIDA’s mission is to advance the science of drug use and addiction and to apply that knowledge to
improve individual and public health.
2. What percentage of the risk for developing a substance use disorder (SUD) with nicotine and opioids
is associated with heritability?
A. 10%
B. 20%
*C. 50%
D. 45%
Answer: C) 50%
Rationale: Heritability accounts for approximately 50% of the risk for developing a SUD with
nicotine and opioids showing the most substance-specific genetic factors. The genome-wide
association studies identified multiple candidate genes associated with SUDs; however, these carry a
small risk.
3. SUDs are determined by how many criteria?
A. 1
1
, B. 1
C. 4
*D. 3
Answer: D) 3
Rationale: SUDs exist on a continuum, ranging from mild to severe. The severity of the disorder is
determined by the number of criteria met for the SUD. (Mild is 2–3 criteria, moderate is 4–5 criteria,
and severe is 6 or more criteria.)
4. What is the percentage of global deaths that are attributable to people ages 20 to 39 for alcohol use?
A. 12%
B. 11%
*C. 13.5 %
D. 21%
Answer: C) 13.5%
Rationale: Approximately 13.5% of global deaths, aged 20 to 39, were attributable to alcohol use.
5. Which imaging technique is used to diagnose neurological disorders in alcohol intoxication?
A. X-Ray
*B. CT and MRI
C. Ultrasonography
D. All of the above
Answer: B) CT and MRI
Rationale: CT scan may be performed for signs of head trauma, TBI, altered consciousness,
bleeding, structural abnormalities, or neurological deficits. MRI of the brain may be ordered if the
head CT is inconclusive or for suspicion of neurological disorders.
6. What is alcohol intoxication?
2
, *A. Alcohol intoxication, or alcohol poisoning, refers to the physiological and psychological state
that occurs shortly after heavy alcohol use. Intoxication may develop within minutes to hours
after consumption and often lasts several hours.
B. Alcohol intoxication is an acute and reversible state that occurs when prolonged use is abruptly
discontinued or significantly reduced.
C. Alcohol intoxication, or alcohol poisoning, refers to the physiological and psychological state that
occurs shortly after heavy alcohol use. Intoxication may develop within minutes to hours after
consumption and often short lasting.
D. Alcohol intoxication, or alcohol poisoning, refers to the neurological state that occurs shortly after
heavy alcohol use. Intoxication may develop within minutes to hours after consumption and often
lasts several hours.
Answer: A) Alcohol intoxication, or alcohol poisoning, refers to the physiological and
psychological state that occurs shortly after heavy alcohol use. Intoxication may develop within
minutes to hours after consumption and often lasts several hours.
Rationale: Alcohol intoxication, or alcohol poisoning, refers to the physiological and psychological
state that occurs shortly after heavy alcohol use. Intoxication may develop within minutes to hours
after consumption and often lasts several hours. Common signs and symptoms of alcohol intoxication
include slurred speech, altered concentration, impaired judgment, confusion, memory impairment,
unsteady gait, nystagmus, mood changes, dysautonomia, and poor coordination.
7. Which gene variants are responsible for encoding alcohol-metabolizing enzymes in Alcohol
Withdrawal?
*A. ADH1B and ALDH2
B. GABA receptors
C. Cinnamyl alcohol dehydrogenase (CAD)
D. All of the above
Answer: A) ADH1B and ALDH2
3
Mental Health Management for Nurse
Practitioners, 3rd Edition Rhoads
Notes
1- The file is chapter after chapter.
2- We have shown you few pages sample.
3- The file contains all Appendix and Excel sheet
if it exists.
4- We have all what you need, we make update
at every time. There are many new editions
waiting you.
5- If you think you purchased the wrong file You
can contact us at every time, we can replace it
with true one.
Our email:
,Clinical Consult to Psychiatric Mental Health
Management for Nurse Practitioners
Third Edition
Jacqueline Rhoads, PhD, ACNP-BC, ANP-C, PMHNP-BE, FAANP
Editor
Copyright © Springer Publishing Company
,Copyright © 2025 Springer Publishing Company, LLC
All rights reserved.
No part of this publication may be reproduced, stored in a retrieval system, or transmitted in
any form or by any means, electronic, mechanical, photocopying, recording, or otherwise,
without the prior permission of Springer Publishing Company, LLC, or authorization through
payment of the appropriate fees to the Copyright Clearance Center, Inc., 222 Rosewood
Drive, Danvers, MA 01923, 978-750-8400, fax 978-646-8600, or at
www.copyright.com.
Springer Publishing Company, LLC
902 Carnegie Center/Suite 140, Princeton, NJ 08540
www.springerpub.com
connect.springerpub.com
ISBN: 978-0-8261-5699-0
The author and the publisher of this Work have made every effort to use sources believed to
be reliable to provide information that is accurate and compatible with the standards
generally accepted at the time of publication. Because medical science is continually
advancing, our knowledge base continues to expand. Therefore, as new information
becomes available, changes in procedures become necessary. We recommend that the
reader always consult current research and specific institutional policies before performing
any clinical procedure or delivering any medication. The author and publisher shall not be
liable for any special, consequential, or exemplary damages resulting, in whole or in part,
from the readers’ use of, or reliance on, the information contained in this book. The publisher
has no responsibility for the persistence or accuracy of URLs for external or third-party
Copyright © Springer Publishing Company
,Internet websites referred to in this publication and does not guarantee that any content on
such websites is, or will remain, accurate or appropriate.
Copyright © Springer Publishing Company
, Contents
Chapters 1–7 intentionally omitted from the Test Bank
Chapter 8: Substance-Related and Addictive Disorders 1
Chapter 9: Psychotic Disorders 6
Chapter 10: Bipolar and Related Disorders 10
Chapter 11: Anxiety Disorders 14
Chapter 12: Obsessive-Compulsive and Related Disorders 18
Chapter 13: Depressive Disorders 22
Chapter 14: Somatoform Disorders 27
Chapter 15: Dissociative Disorders 31
Chapter 16: Sexual Dysfunction 35
Chapter 17: Feeding and Eating Disorders 40
Chapter 18: Personality Disorders 45
Chapter 19: Sleep–Wake Disorders 50
Chapter 20: Trauma and Stressor-Related Disorders 55
Chapter 21: Disruptive, Impulse Control, and Conduct
Disorders 60
Copyright © Springer Publishing Company
,Chapter 22: Disorders Usually Presenting in Childhood 64
Chapter 23: Neurocognitive Disorders 68
Copyright © Springer Publishing Company
, Chapter 8
Substance-Related and Addictive Disorders
1. Which institution describes the effective treatment principles of substance use disorders?
A. Anti-Drug Abuse Committee
B. Narcotics Control Bureau (NCB)
C. National Centre for Drug Abuse (NCD)
*D. The National Institute on Drug Abuse (NIDA)
Answer: D) The National Institute on Drug Abuse (NIDA)
Rationale: The National Institute on Drug Abuse (NIDA) outlines effective treatment principles as
NIDA’s mission is to advance the science of drug use and addiction and to apply that knowledge to
improve individual and public health.
2. What percentage of the risk for developing a substance use disorder (SUD) with nicotine and opioids
is associated with heritability?
A. 10%
B. 20%
*C. 50%
D. 45%
Answer: C) 50%
Rationale: Heritability accounts for approximately 50% of the risk for developing a SUD with
nicotine and opioids showing the most substance-specific genetic factors. The genome-wide
association studies identified multiple candidate genes associated with SUDs; however, these carry a
small risk.
3. SUDs are determined by how many criteria?
A. 1
1
, B. 1
C. 4
*D. 3
Answer: D) 3
Rationale: SUDs exist on a continuum, ranging from mild to severe. The severity of the disorder is
determined by the number of criteria met for the SUD. (Mild is 2–3 criteria, moderate is 4–5 criteria,
and severe is 6 or more criteria.)
4. What is the percentage of global deaths that are attributable to people ages 20 to 39 for alcohol use?
A. 12%
B. 11%
*C. 13.5 %
D. 21%
Answer: C) 13.5%
Rationale: Approximately 13.5% of global deaths, aged 20 to 39, were attributable to alcohol use.
5. Which imaging technique is used to diagnose neurological disorders in alcohol intoxication?
A. X-Ray
*B. CT and MRI
C. Ultrasonography
D. All of the above
Answer: B) CT and MRI
Rationale: CT scan may be performed for signs of head trauma, TBI, altered consciousness,
bleeding, structural abnormalities, or neurological deficits. MRI of the brain may be ordered if the
head CT is inconclusive or for suspicion of neurological disorders.
6. What is alcohol intoxication?
2
, *A. Alcohol intoxication, or alcohol poisoning, refers to the physiological and psychological state
that occurs shortly after heavy alcohol use. Intoxication may develop within minutes to hours
after consumption and often lasts several hours.
B. Alcohol intoxication is an acute and reversible state that occurs when prolonged use is abruptly
discontinued or significantly reduced.
C. Alcohol intoxication, or alcohol poisoning, refers to the physiological and psychological state that
occurs shortly after heavy alcohol use. Intoxication may develop within minutes to hours after
consumption and often short lasting.
D. Alcohol intoxication, or alcohol poisoning, refers to the neurological state that occurs shortly after
heavy alcohol use. Intoxication may develop within minutes to hours after consumption and often
lasts several hours.
Answer: A) Alcohol intoxication, or alcohol poisoning, refers to the physiological and
psychological state that occurs shortly after heavy alcohol use. Intoxication may develop within
minutes to hours after consumption and often lasts several hours.
Rationale: Alcohol intoxication, or alcohol poisoning, refers to the physiological and psychological
state that occurs shortly after heavy alcohol use. Intoxication may develop within minutes to hours
after consumption and often lasts several hours. Common signs and symptoms of alcohol intoxication
include slurred speech, altered concentration, impaired judgment, confusion, memory impairment,
unsteady gait, nystagmus, mood changes, dysautonomia, and poor coordination.
7. Which gene variants are responsible for encoding alcohol-metabolizing enzymes in Alcohol
Withdrawal?
*A. ADH1B and ALDH2
B. GABA receptors
C. Cinnamyl alcohol dehydrogenase (CAD)
D. All of the above
Answer: A) ADH1B and ALDH2
3
